Clinical Trials Logo

Gastric Carcinoma Stage IV clinical trials

View clinical trials related to Gastric Carcinoma Stage IV.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04442984 Recruiting - Clinical trials for Gastric Carcinoma Stage IV

FOLFOX6 Versus mFOLFIRINOX as First Line Chemotherapy in Metastatic Gastric Cancer or Esophagogastric Junction Adenocarcinoma (Type II-III)

IRIGA
Start date: November 3, 2019
Phase: Phase 2
Study type: Interventional

Patients with metastatic adenocarcinoma of the stomach or the esophagogastric junction (II-III type by Siewert) without previous therapy will be treated with one of two chemotherapy combinations . One half of the patients gets 5-Fluorouracil (5-FU), Leucovorin, Oxaliplatin (FOLFOX6), the others 5-Fluorouracil (5-FU), Leucovorin, Oxaliplatin and Irinotecan (mFOLFIRINOX). Main objective of the study is progression free survival.